Shenzhen Edge Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	625.65	455.72	159.99	48.04
Revenue Growth	124.14%	184.83%	233.03%	-
Cost of Revenue	214.22	155.06	61.92	43.48
Gross Profit	411.43	300.65	98.08	4.56
Selling, General & Admin	241.2	225.32	153.84	100.23
Research & Development	142.54	185.2	226.25	171.23
Operating Expenses	399.97	417.96	381.12	272.01
Operating Income	11.46	-117.31	-283.04	-267.44
Interest Expense	-0.85	-0.54	-0.86	-0.99
Interest & Investment Income	21.97	13.9	15.03	5.36
Earnings From Equity Investments	-0.03	-0.09	-	-
Currency Exchange Gain (Loss)	-49.18	-2.44	-0.12	0.18
Other Non Operating Income (Expenses)	8.41	4.51	30.71	3
EBT Excluding Unusual Items	-8.22	-101.97	-238.29	-259.89
Gain (Loss) on Sale of Investments	-10.57	13.36	21.21	47.02
Asset Writedown	-	-	-1.43	-
Pretax Income	-18.8	-88.61	-218.51	-212.87
Net Income	-18.77	-88.61	-218.51	-212.87
Net Income to Common	-18.77	-88.61	-218.51	-212.87
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	375	360	360	360
Shares Outstanding (Diluted)	375	360	360	360
Shares Change	4.14%	-	-	-
EPS (Basic)	-0.05	-0.25	-0.61	-0.59
EPS (Diluted)	-0.05	-0.25	-0.61	-0.59
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-228.69	-197.74	-251.03	-381.64
Free Cash Flow Per Share	-0.61	-0.55	-0.70	-1.06
Gross Margin	65.76%	65.97%	61.30%	9.49%
Operating Margin	1.83%	-25.74%	-176.91%	-556.69%
Profit Margin	-3.00%	-19.44%	-136.57%	-443.09%
Free Cash Flow Margin	-36.55%	-43.39%	-156.90%	-794.39%
EBITDA	28.37	-98.06	-262.54	-259.09
EBITDA Margin	4.53%	-21.52%	-164.09%	-
D&A For EBITDA	16.9	19.24	20.5	8.36
EBIT	11.46	-117.31	-283.04	-267.44
EBIT Margin	1.83%	-25.74%	-176.91%	-